San Diego-centered Viking Therapeutics marked alone as a serious competitor within the weight loss drug current market in February immediately after revealing promising information from the mid-phase trial of experimental drug VK2735, which suggested it rivaled—and outperformed—Novo and Lilly drugs when provided for a weekly injection As well a… Read More